BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6176411)

  • 1. Serum activities of lysosomal enzymes in patients with liver cell carcinoma.
    Nagasue N; Inokuchi K; Kanashima R
    Dig Dis Sci; 1982 May; 27(5):454-8. PubMed ID: 6176411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Release of lysosomal enzymes after partial hepatectomy: study of patients with and without cirrhosis of the liver.
    Nagasue N; Inokuchi K; Kanashima R
    Arch Surg; 1982 Jun; 117(6):772-6. PubMed ID: 6282236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum glutamic oxalacetic transaminase/glutamic pyruvic transaminase ratios in hepatocellular carcinoma.
    Shimokawa Y; Okuda K; Kubo Y; Kaneko A; Arishima T; Nagata E; Hashimoto M; Sawa Y; Nagasaki Y; Kojiro M; Sakamoto K; Nakashima T
    Cancer; 1977 Jul; 40(1):319-24. PubMed ID: 195707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Measurement of serum immunoreactive beta-glucuronidase: a possible serological marker for histological hepatic cell necrosis and to predict the histological progression of hepatitis].
    Ohta H
    Hokkaido Igaku Zasshi; 1991 Jul; 66(4):545-57. PubMed ID: 1655603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significance of type III procollagen peptide in sera of patients with liver cancer].
    Yamauchi M; Nakayama H; Fukuzawa K; Nakajima H; Takahara M; Nakahara M; Kawase H; Watanabe Y; Kimura K; Kitahara T
    Gan No Rinsho; 1984 Jun; 30(7):785-90. PubMed ID: 6086978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Enzyme diagnosis in primary liver carcinoma].
    Schmidt E; Schmidt FW
    Dtsch Med Wochenschr; 1968 Jun; 93(23):1153-5. PubMed ID: 5648362
    [No Abstract]   [Full Text] [Related]  

  • 7. Elevation of serum type IV collagen in liver cancer as well as liver cirrhosis.
    Hong WS; Hong SI; Park SY; Son Y; Lee YS; Chung YH; Yang SK; Suh DJ; Min YI
    Anticancer Res; 1995; 15(6B):2777-80. PubMed ID: 8669863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanism of the release of hepatic enzymes in various liver diseases. 1. Alterations in cytoplasmic and mitochondrial enzyme activities in serum.
    Miyake S
    Acta Med Okayama; 1979 Aug; 33(4):287-304. PubMed ID: 227231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between serum enzymes and serum unsaturated vitamin B12 binding proteins in primary liver carcinoma.
    Osifo BO; Ayoola A; Parmentier Y; Gerard P; Nicolas JP
    Enzyme; 1988; 39(3):161-6. PubMed ID: 2837386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of endotoxin administration on hepatic function of rats with altered endotoxin sensitivity.
    Di Luzio NR; Trejo RA; Crafton CC
    J Reticuloendothel Soc; 1972 Jun; 11(6):637-53. PubMed ID: 5046176
    [No Abstract]   [Full Text] [Related]  

  • 11. The relationship between hepatitis-associated antigen and the development of hepatocellular cancer.
    Theodoropoulos G; Economopoulos P; Mitakos S; Angelopoulos Ba
    Acta Hepatogastroenterol (Stuttg); 1974 Dec; 21(6):430-2. PubMed ID: 4377058
    [No Abstract]   [Full Text] [Related]  

  • 12. N-acetylglucosaminyltransferase III in human serum, and liver and hepatoma tissues: increased activity in liver cirrhosis and hepatoma patients.
    Ishibashi K; Nishikawa A; Hayashi N; Kasahara A; Sato N; Fujii S; Kamada T; Taniguchi N
    Clin Chim Acta; 1989 Dec; 185(3):325-32. PubMed ID: 2482796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysosomal enzymes in sera and granulocytes of patients with chronic liver diseases.
    Fehér J; Toncsev H; Fehér E; Kiss A; Vasady A
    Int J Tissue React; 1981 Mar; 3(1):31-7. PubMed ID: 7287055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective evaluation of serum markers APRI and AST/ALT for assessing liver fibrosis and cirrhosis in chronic hepatitis B and C patients with hepatocellular carcinoma.
    Lin CS; Chang CS; Yang SS; Yeh HZ; Lin CW
    Intern Med; 2008; 47(7):569-75. PubMed ID: 18379139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proceedings: Primary liver cancer. A review of the clinical features, blood groups, serum enzymes, therapy, and survival of 65 cases.
    al-Sarraf M; Go TS; Kithier K; Vaitkevicius VK
    Cancer; 1974 Feb; 33(2):574-82. PubMed ID: 4360057
    [No Abstract]   [Full Text] [Related]  

  • 16. [Enzymatic parameters in diagnosis of fatty liver ].
    Nilius R; Peters JE; Farr W; Gründig CA; Otto L; Busse HJ; Zipprich B; Eismann R; Mantel E
    Z Gesamte Inn Med; 1973 Sep; 28(17):268-70 passim. PubMed ID: 4148891
    [No Abstract]   [Full Text] [Related]  

  • 17. Selective secretion of lysosomal enzymes of the Yoshida hepatoma AH 130 in the peritoneal fluid.
    Hegner D; Platt D
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1972 Dec; 78(4):310-6. PubMed ID: 4354866
    [No Abstract]   [Full Text] [Related]  

  • 18. Lysosomal cathepsins B and L and Stefin A blood levels in patients with hepatocellular carcinoma and/or liver cirrhosis: potential clinical implications.
    Leto G; Tumminello FM; Pizzolanti G; Montalto G; Soresi M; Gebbia N
    Oncology; 1997; 54(1):79-83. PubMed ID: 8978598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma lysosomal enzymes after liver transplantation in the pig.
    Chang CW; Imai K; Chang YC; Hayashi T; Kohno H; Nagasue N; Nakamura T
    Enzyme; 1991; 45(3):145-54. PubMed ID: 1815948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant differences in serum activities of matrix metalloproteinase-2 and -9 between HCV- and HBV-infected patients and carriers.
    Kuo WH; Chou FP; Lu SC; Chu SC; Hsieh YS
    Clin Chim Acta; 2000 Apr; 294(1-2):157-68. PubMed ID: 10727681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.